Back to Directory
Last Updated: 04/06/2026

SymphoRNA

Stevenage
Founded 2025
RNA therapeutics platform targeting multiple disease pathways

SymphoRNA is a company developing RNA medicines designed to address complex diseases by targeting multiple biological pathways simultaneously.

Its platform uses a polysaccharide-based delivery system to enable combination RNA therapies, with the aim of achieving outcomes that single-target approaches cannot.

Spun out from Uncommon Bio in 2025, the company operates from Cambridge and Stevenage Bioscience Catalyst.

BiotechMolecular Biology Tools
RNA ManufacturingRNA Therapeutics

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page

Company Notes

Member of